Constantine Davides
Stock Analyst at JMP Securities
(0.83)
# 2,818
Out of 4,479 analysts
66
Total ratings
26.56%
Success rate
-27.9%
Average return
Main Sectors:
26 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OPRX OptimizeRx | Reiterates: Market Outperform | $16 | $10.07 | +58.89% | 5 | Jun 24, 2024 | |
| HQY HealthEquity | Maintains: Market Outperform | $101 → $105 | $85.76 | +22.43% | 2 | Jun 4, 2024 | |
| EVH Evolent Health | Maintains: Market Outperform | $38 → $34 | $19.25 | +76.62% | 3 | May 10, 2024 | |
| AMN AMN Healthcare Services | Reiterates: Market Outperform | $75 | $49.77 | +50.69% | 4 | May 10, 2024 | |
| CERT Certara | Initiates: Market Perform | n/a | $13.66 | - | 1 | Apr 4, 2024 | |
| PRVA Privia Health Group | Initiates: Market Outperform | $27 | $17.16 | +57.34% | 1 | Dec 6, 2023 | |
| HSTM HealthStream | Initiates: Market Perform | n/a | $27.75 | - | 1 | Dec 6, 2023 | |
| CCRN Cross Country Healthcare | Initiates: Market Perform | n/a | $13.65 | - | 1 | Dec 6, 2023 | |
| AGL agilon health | Initiates: Market Outperform | $18 | $5.88 | +206.12% | 1 | Dec 6, 2023 | |
| NMRD Nemaura Medical | Maintains: Buy | $6 → $4 | $0.04 | +10,426.32% | 4 | Jul 17, 2023 | |
| NNVC NanoViricides | Assumes: Buy | $5.25 | $1.78 | +194.94% | 3 | Jun 1, 2023 | |
| MEDS TRxADE HEALTH | Maintains: Buy | $26 → $19 | $18.49 | +1.41% | 2 | May 16, 2023 | |
| LGVN Longeveron | Reiterates: Buy | $125 | $1.68 | +7,340.48% | 5 | May 16, 2023 | |
| ELMD Electromed | Reiterates: Buy | $15 | $14.00 | +7.14% | 3 | May 11, 2023 | |
| INVA Innoviva | Reiterates: Buy | $23 | $16.50 | +36.36% | 4 | May 10, 2023 | |
| CCLD CareCloud | Reiterates: Buy | $8.5 | $2.29 | +271.18% | 2 | May 5, 2023 | |
| HOTH Hoth Therapeutics | Reiterates: Buy | $14 | $0.88 | +1,485.50% | 4 | Apr 27, 2023 | |
| HCWB HCW Biologics | Reiterates: Buy | $9 | $0.62 | +1,351.61% | 4 | Apr 19, 2023 | |
| BBLG Bone Biologics | Reiterates: Buy | $540 | $1.22 | +44,162.30% | 3 | Apr 13, 2023 | |
| KTTA Pasithea Therapeutics | Maintains: Buy | $46 → $40 | $5.16 | +675.95% | 2 | Apr 3, 2023 | |
| VNRX VolitionRx | Reiterates: Buy | $6 | $0.63 | +852.38% | 2 | Mar 16, 2023 | |
| ACST Acasti Pharma | Reiterates: Buy | $15 | $2.85 | +426.32% | 2 | Feb 15, 2023 | |
| BIVI BioVie | Maintains: Buy | $14 → $8 | $0.40 | +1,877.26% | 2 | Sep 28, 2022 | |
| HCTI Healthcare Triangle | Maintains: Buy | $40 → $20 | $0.48 | +4,110.53% | 2 | Sep 28, 2022 | |
| ISPC iSpecimen | Maintains: Buy | $5.5 → $4.25 | $0.29 | +1,341.66% | 2 | Sep 23, 2022 | |
| TCBP TC Biopharm (Holdings) | Initiates: Buy | $50,000 | $0.89 | +5,609,683.46% | 1 | Mar 28, 2022 |
OptimizeRx
Jun 24, 2024
Reiterates: Market Outperform
Price Target: $16
Current: $10.07
Upside: +58.89%
HealthEquity
Jun 4, 2024
Maintains: Market Outperform
Price Target: $101 → $105
Current: $85.76
Upside: +22.43%
Evolent Health
May 10, 2024
Maintains: Market Outperform
Price Target: $38 → $34
Current: $19.25
Upside: +76.62%
AMN Healthcare Services
May 10, 2024
Reiterates: Market Outperform
Price Target: $75
Current: $49.77
Upside: +50.69%
Certara
Apr 4, 2024
Initiates: Market Perform
Price Target: n/a
Current: $13.66
Upside: -
Privia Health Group
Dec 6, 2023
Initiates: Market Outperform
Price Target: $27
Current: $17.16
Upside: +57.34%
HealthStream
Dec 6, 2023
Initiates: Market Perform
Price Target: n/a
Current: $27.75
Upside: -
Cross Country Healthcare
Dec 6, 2023
Initiates: Market Perform
Price Target: n/a
Current: $13.65
Upside: -
agilon health
Dec 6, 2023
Initiates: Market Outperform
Price Target: $18
Current: $5.88
Upside: +206.12%
Nemaura Medical
Jul 17, 2023
Maintains: Buy
Price Target: $6 → $4
Current: $0.04
Upside: +10,426.32%
NanoViricides
Jun 1, 2023
Assumes: Buy
Price Target: $5.25
Current: $1.78
Upside: +194.94%
TRxADE HEALTH
May 16, 2023
Maintains: Buy
Price Target: $26 → $19
Current: $18.49
Upside: +1.41%
Longeveron
May 16, 2023
Reiterates: Buy
Price Target: $125
Current: $1.68
Upside: +7,340.48%
Electromed
May 11, 2023
Reiterates: Buy
Price Target: $15
Current: $14.00
Upside: +7.14%
Innoviva
May 10, 2023
Reiterates: Buy
Price Target: $23
Current: $16.50
Upside: +36.36%
CareCloud
May 5, 2023
Reiterates: Buy
Price Target: $8.5
Current: $2.29
Upside: +271.18%
Hoth Therapeutics
Apr 27, 2023
Reiterates: Buy
Price Target: $14
Current: $0.88
Upside: +1,485.50%
HCW Biologics
Apr 19, 2023
Reiterates: Buy
Price Target: $9
Current: $0.62
Upside: +1,351.61%
Bone Biologics
Apr 13, 2023
Reiterates: Buy
Price Target: $540
Current: $1.22
Upside: +44,162.30%
Pasithea Therapeutics
Apr 3, 2023
Maintains: Buy
Price Target: $46 → $40
Current: $5.16
Upside: +675.95%
VolitionRx
Mar 16, 2023
Reiterates: Buy
Price Target: $6
Current: $0.63
Upside: +852.38%
Acasti Pharma
Feb 15, 2023
Reiterates: Buy
Price Target: $15
Current: $2.85
Upside: +426.32%
BioVie
Sep 28, 2022
Maintains: Buy
Price Target: $14 → $8
Current: $0.40
Upside: +1,877.26%
Healthcare Triangle
Sep 28, 2022
Maintains: Buy
Price Target: $40 → $20
Current: $0.48
Upside: +4,110.53%
iSpecimen
Sep 23, 2022
Maintains: Buy
Price Target: $5.5 → $4.25
Current: $0.29
Upside: +1,341.66%
TC Biopharm (Holdings)
Mar 28, 2022
Initiates: Buy
Price Target: $50,000
Current: $0.89
Upside: +5,609,683.46%